This study aimed to assess the relationship between age-related changes in Neurofilament
Light Chain (NFL), a marker of neuronal function, and various factors including muscle …

Background Efforts to enhance diagnostic measures for sarcopenia have led to an
increased focus on the screening utility of blood‐based biomarkers. In this regard …

Objective: Serum neurofilament light (sNfL) is a promising marker for neuro-axonal damage
and it is now well known that its levels also increase with higher age. However, the effect of …

Neurofilament light chain (NfL) is a novel biomarker of neurodegenerative diseases. It is
detectable in the peripheral blood, allowing low-invasive assessment of early signs of …

Aims This study aimed to determine the association of plasma neurofilament light (NfL), a
marker of neurodegeneration, with diabetes status and glycaemic parameters in people with …

Background Several studies have reported the association between blood neurofilament
light chain (NfL) levels and all-cause mortality. However, the generalizability of these …

Neurofilament light chain (NfL) is a neuron-specific structural protein released into the
extracellular space, including body fluids, upon neuroaxonal damage. Despite evidence of a …

Background Blood biomarkers can offer valuable and easily accessible indicators of normal
biological processes, pathogenic conditions, and responses to therapeutic interventions …

Neurofilament light chain (NfL) has emerged as a promising blood biomarker for the
progression of various neurological diseases. NfL is a structural protein of nerve cells, and …

Background Plasma neurofilament light chain (NfL) is a novel biomarker for age-related
neurodegenerative disease. We tested whether NfL may be linked to cardiometabolic risk …